Clinical outcomes and correlates of TP53 mutations and cancer.
Robles
Ana I
AI
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Harris
Curtis C
CC
D015415:Biomarkers; D004252:DNA Mutational Analysis; D016158:Genes, p53; D014644:Genetic Variation; D018095:Germ-Line Mutation; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy*; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D011740:Pyrimidine Dimers / Q000235:genetics; D012306:Risk; D013472:Sunlight; D016896:Treatment Outcome
D015415:Biomarkers; D011740:Pyrimidine Dimers